Shanghai Pharmaceuticals Holding Co
Dawei Jiang is an experienced business development professional specializing in the pharmaceutical sector. Currently serving as BD Director at 上海医药集团股份有限公司 since January 2020, Dawei Jiang has successfully executed a pre-clinical licensing deal with HUYABIO International. Prior roles include Senior Director of Business Development & Licensing at ApolloBio, where leadership in closing two late clinical stage licensing agreements for Greater China was demonstrated. Additional experience encompasses positions such as Director of Business Development at ApolloBio Corp., Partner at Hollyhigh International Capital, and General Manager of Overseas Business at Holley Cotec Pharmaceuticals. Dawei Jiang's educational background includes a Bachelor's degree in Pharmacy from Peking University and an MBA from the University of International Business and Economics.
This person is not in any teams
This person is not in any offices
Shanghai Pharmaceuticals Holding Co
1 followers
Shanghai Pharmaceuticals Holding Co is a China-based company principally engaged in the manufacture and sales of pharmaceuticals. The Company's businesses include the research and registration, production, sales, distribution and retailing of pharmaceutical products, among others. Its products are applied in cardiovascular system, anti-cancer and immunoregulation, anti-infection and metabolism, as well as other fields. The Company operates businesses in domestic and overseas markets.